CMMB

$1.271.61%0.0201

Chemomab Therapeutics Ltd Adr (CMMB)

Chemomab Therapeutics Ltd Adr Stock (CMMB) Forecast

The Chemomab Therapeutics Ltd Adr (CMMB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.29, representing a +1.17% increase from the current price of $1.27. The highest analyst price target is $1.60, and the lowest is $0.9701.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month CMMB Price Target

Average 2.84 (+123.92% Upside)

Is Chemomab Therapeutics Ltd Adr (CMMB) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	45.14	Neutral
STOCH(9,6)	74.48	Neutral
STOCHRSI(14)	100.00	Sell
MACD(12,26)	-0.12	Buy
ADX(14)	33.69	Sell
William %R	-14.61	Sell
CCI(14)	65.04	Neutral

Buy: 1 · Sell: 3 · Neutral: 3Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	1.15 Buy	1.20 Buy
MA20	1.18 Buy	1.26 Buy
MA50	1.78 Sell	1.53 Sell
MA100	1.78 Sell	1.69 Sell
MA200	1.74 Sell	1.80 Sell

Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell

According to our latest analysis, CMMB could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CMMB, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 45.14 indicates that CMMB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 74.48 indicates that CMMB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that CMMB is overbought. This suggests that CMMB price is at or near the highest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 33.69 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 65.04 indicates that CMMB is still overbought but not to an extreme extent.

Long-term CMMB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Chemomab Therapeutics Ltd Adr financial reports and earnings history, Chemomab Therapeutics Ltd Adr (CMMB) stock could reach $2.92 by 2030, $16.67 by 2040 and $35.48 by 2050. See the projected annual prices until 2050 of the Chemomab Therapeutics Ltd Adr stock below:

Chemomab Therapeutics Ltd Adr (CMMB) is expected to reach an average price of $6.14 in 2035, with a high prediction of $9.87 and a low estimate of $6.22. This indicates an +383.04% change from the last recorded price of $1.27.
Chemomab Therapeutics Ltd Adr (CMMB) stock is projected to chart a bullish course in 2040, with an average price target of $13.55, representing an +966.54% change from its current level. The forecast ranges from a conservative $13.63 to a sky-high $16.67.
Our analysts predict Chemomab Therapeutics Ltd Adr (CMMB) to change +1,606% by 2045, soaring from $21.75 to an average price of $21.67, potentially reaching $25.52. While $21.75 is the low estimate, the potential upside is significant.
Chemomab Therapeutics Ltd Adr (CMMB) stock is expected to climb by 2050, reaching an average of $30.75, a +2,321% change from its current level. However, a wide range of estimates exists, with high and low targets of $35.48 and $30.90, respectively, highlighting the market's uncertainty.

Chemomab Therapeutics Ltd Adr Stock (CMMB) Year by Year Forecast

Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2026

The predicted value for Chemomab Therapeutics Ltd Adr (CMMB) in 2026 is set at an average of $1.53. Estimates vary from a peak of $2.99 to a trough of $0.0324, indicating an +20.07% surge from the present price of $1.27.

Month	Average	Low	High	Change from today's price
December, 2026	$0.7451	$0.9701	$1.60	-41.34%

Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Chemomab Therapeutics Ltd Adr (CMMB) is $4.00, with a high forecast of $4.94 and a low forecast of $1.71. This indicates an +214.81% increase from the last price of $1.27.

Month	Average	Low	High	Change from today's price
January, 2027	$2.80	$1.71	$1.45	+120.07%
February, 2027	$3.74	$3.44	$3.10	+194.09%
March, 2027	$3.76	$4.09	$3.90	+196.06%
April, 2027	$3.03	$3.14	$3.32	+138.59%
May, 2027	$4.71	$3.83	$4.47	+270.47%
June, 2027	$4.56	$4.62	$4.64	+258.67%
July, 2027	$3.44	$4.31	$4.11	+170.49%
August, 2027	$4.17	$4.00	$3.91	+228.37%
September, 2027	$3.97	$4.05	$4.13	+212.62%
October, 2027	$3.75	$4.00	$3.86	+195.31%
November, 2027	$5.09	$4.23	$4.72	+300.42%
December, 2027	$4.99	$5.01	$4.94	+292.55%

Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2028

In 2028, Chemomab Therapeutics Ltd Adr (CMMB) is projected to reach an average price of $4.56, with a high projection of $4.89 and a low estimate of $4.48. This indicates an +259.32% rise from the last price of $1.27.

Month	Average	Low	High	Change from today's price
January, 2028	$4.66	$4.84	$4.79	+266.97%
February, 2028	$3.56	$4.56	$4.39	+180.37%
March, 2028	$4.58	$4.51	$4.37	+260.68%
April, 2028	$4.60	$4.49	$4.47	+262.26%
May, 2028	$4.97	$4.96	$4.89	+291.00%
June, 2028	$4.72	$4.87	$4.78	+271.32%
July, 2028	$4.42	$4.70	$4.72	+247.71%
August, 2028	$4.42	$4.48	$4.55	+248.11%
September, 2028	$4.76	$4.58	$4.61	+274.88%
October, 2028	$4.64	$4.64	$4.59	+265.04%
November, 2028	$4.68	$4.74	$4.68	+268.20%
December, 2028	$4.77	$4.69	$4.60	+275.29%

Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2029

The 2029 price forecast for Chemomab Therapeutics Ltd Adr Stock (CMMB) is $4.21 on average, with a high prediction of $4.86 and a low estimate of $3.31. This represents an +231.85% increase from the previous price of $1.27.

Month	Average	Low	High	Change from today's price
January, 2029	$4.76	$4.76	$4.73	+275.14%
February, 2029	$4.89	$4.84	$4.74	+285.20%
March, 2029	$4.87	$4.88	$4.86	+283.57%
April, 2029	$4.68	$4.74	$4.83	+268.30%
May, 2029	$4.57	$4.61	$4.66	+259.57%
June, 2029	$4.35	$4.40	$4.48	+242.64%
July, 2029	$4.13	$4.19	$4.34	+225.40%
August, 2029	$4.17	$4.11	$4.13	+228.49%
September, 2029	$3.87	$3.90	$4.06	+204.79%
October, 2029	$3.66	$3.66	$3.81	+187.94%
November, 2029	$3.37	$3.44	$3.55	+165.11%
December, 2029	$3.25	$3.31	$3.28	+156.06%

Chemomab Therapeutics Ltd Adr Stock (CMMB) Price Forecast for 2030

Chemomab Therapeutics Ltd Adr Stock (CMMB) is expected to reach an average price of $2.13 in 2030, with a high forecast of $2.92 and a low forecast of $1.65. This signifies an +67.41% surge from the last price of $1.27.

Month	Average	Low	High	Change from today's price
January, 2030	$2.48	$2.47	$2.92	+95.05%
February, 2030	$2.65	$2.63	$2.49	+108.83%
March, 2030	$2.64	$2.67	$2.55	+108.05%
April, 2030	$2.12	$2.37	$2.58	+66.72%
May, 2030	$1.83	$2.27	$2.16	+43.89%
June, 2030	$1.60	$1.68	$1.73	+25.79%
July, 2030	$1.90	$1.65	$1.55	+49.81%
August, 2030	$2.23	$2.16	$2.04	+75.79%
September, 2030	$2.27	$2.31	$2.35	+78.55%
October, 2030	$2.03	$1.97	$2.01	+59.66%
November, 2030	$1.87	$1.92	$1.86	+46.94%
December, 2030	$1.90	$1.91	$1.89	+49.83%

Similar to CMMB